U.S. markets open in 6 hours 26 minutes

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.08+0.60 (+3.64%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/18/2021
Current
6/30/20213/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
1.16B935.77M3.57B4.30B3.79B3.96B
Enterprise Value 3
917.40M629.52M3.20B3.89B3.34B3.80B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
54.3013.2052.2755.8043.81101.61
Price/Book (mrq)
3.512.599.2510.598.9965.81
Enterprise Value/Revenue 3
43.32370.53313.11920.07663.5477.13
Enterprise Value/EBITDA 7
-7.75-16.78-110.74-135.13-142.79176.86

Trading Information

Stock Price History

Beta (5Y Monthly) 1.45
52-Week Change 3-67.66%
S&P500 52-Week Change 334.63%
52 Week High 370.29
52 Week Low 39.53
50-Day Moving Average 315.21
200-Day Moving Average 324.73

Share Statistics

Avg Vol (3 month) 32.17M
Avg Vol (10 day) 31.34M
Shares Outstanding 569.9M
Implied Shares Outstanding 6N/A
Float 50.13M
% Held by Insiders 123.31%
% Held by Institutions 164.88%
Shares Short (Aug 30, 2021) 44.47M
Short Ratio (Aug 30, 2021) 43.6
Short % of Float (Aug 30, 2021) 49.45%
Short % of Shares Outstanding (Aug 30, 2021) 46.39%
Shares Short (prior month Jul 29, 2021) 44.99M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-562.29%

Management Effectiveness

Return on Assets (ttm)-15.04%
Return on Equity (ttm)-32.70%

Income Statement

Revenue (ttm)21.61M
Revenue Per Share (ttm)0.31
Quarterly Revenue Growth (yoy)-96.30%
Gross Profit (ttm)-12.99M
EBITDA -119.86M
Net Income Avi to Common (ttm)-122.86M
Diluted EPS (ttm)-1.77
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)312.6M
Total Cash Per Share (mrq)4.47
Total Debt (mrq)71.7M
Total Debt/Equity (mrq)21.71
Current Ratio (mrq)5.73
Book Value Per Share (mrq)4.73

Cash Flow Statement

Operating Cash Flow (ttm)-74.8M
Levered Free Cash Flow (ttm)-91.93M